Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Singapore To Require GMP Evidence On Chemical Substance Drug Manufacturers
Sep 29 2023
•
By
Vibha Sharma
HSA Wants To Assure The Quality Standard Of Therapeutic Products Supplied In Singapore • Source: Shutterstock
More from Manufacturing
More from Compliance